Welcome to the Schizophrenia Resource Centre

Welcome, this website is intended for healthcare professionals in EMEA with an interest in the treatment of schizophrenia. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Neurogenesis and neurotoxicity: Pt 2 of roundtable with Dr Henry Nasrallah, Dr Jim van Os, and Dr Diana Perkins at ECNP 2014.

In part 2 of this round table, the group suggest that a better understanding of neurogenesis could open up novel pathways in schizophrenia treatment. There is hope that the future is going to elucidate specific pathoetiologies and identify specific treatments. Concerns are raised over treatments that are potentially neurotoxic over a long period of time, compared to treatments that potentially stimulate neurogenesis. They explore the role of microglial activation in schizophrenia and the need to further understand brain plasticity in order to capitalise on it when developing treatments.